Literature DB >> 7250150

Pharmacokinetic study of doxycycline polyphosphate (PPD), hydrochloride (CHD) and base (DB).

M C Saux, J Mosser, H Pontagnier, B Leng.   

Abstract

Six healthy volunteers received the same oral dose of doxycycline, base (200 mg). Each received two of the three preparations at two-week intervals. Experimental results were interpreted on the basis of one or two-compartment models. The three preparations gave the elimination constants of the same order of magnitude (0.045 h-1 to 0.051 h-1). The plasma half-life t 1/2 beta was 14.143 h for DP, 15.400 h for DHC and 13.588 h for DB. Vd is higher for DB (91.955 L) than for DPP (73.401 L) and DHC (64.827 L). Total plasma clearance is 52.767 ml/min for DPP, 48.728 ml/min for DHC and 60.174 ml/min for DB. Urinary elimination 72 hours after administration is 29.24% for DPP, 35.60% and 28.15% for DB. Fluorimetric analysis of some of the samples confirmed the values obtained, with the exception of a few parameters such as Vd and clearance, which were lower. This may result from the fact that this method of determination is more broadly responsive, and is not limited to the evaluation of the active fraction. Relative bioavailability of the capsule form of DPP is 111.15% of that of DHC.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7250150     DOI: 10.1007/BF03189510

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


  3 in total

1.  Per cent absorbed time plots derived from blood level and/or urinary excretion data.

Authors:  J G WAGNER; E NELSON
Journal:  J Pharm Sci       Date:  1963-06       Impact factor: 3.534

2.  [Application of the laws of pharmacokinetics to antibiotics].

Authors:  C Regamey; F A Waldvogel
Journal:  Pathol Biol (Paris)       Date:  1974-11

3.  New method for calculating the intrinsic absorption rate of drugs.

Authors:  J C Loo; S Riegelman
Journal:  J Pharm Sci       Date:  1968-06       Impact factor: 3.534

  3 in total
  5 in total

Review 1.  Clinical pharmacokinetics of doxycycline and minocycline.

Authors:  S Saivin; G Houin
Journal:  Clin Pharmacokinet       Date:  1988-12       Impact factor: 6.447

2.  Pharmacokinetic study of doxycycline polyphosphate+ after simultaneous ingestion of milk.

Authors:  M C Saux; J Mosser; H Pontagnier; B Leng
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1983       Impact factor: 2.441

3.  Pharmacokinetics of doxycycline polyphosphate after oral multiple dosing in humans.

Authors:  M C Saux; J Mosser; H Pontagnier; B Leng
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1982       Impact factor: 2.441

Review 4.  Antimicrobial Treatment Options for Difficult-to-Treat Resistant Gram-Negative Bacteria Causing Cystitis, Pyelonephritis, and Prostatitis: A Narrative Review.

Authors:  Andrew Chou; Elwyn Welch; Andrew Hunter; Barbara W Trautner
Journal:  Drugs       Date:  2022-03-14       Impact factor: 11.431

5.  Suppression of Plasmodium falciparum by serum collected from a case of Plasmodium vivax infection.

Authors:  Yoshiro Nagao; Masako Kimura-Sato; Porntip Chavalitshewinkoon-Petmitr; Supatra Thongrungkiat; Polrat Wilairatana; Takafumi Ishida; Peerapan Tan-Ariya; J Brian de Souza; Srivicha Krudsood; Sornchai Looareesuwan
Journal:  Malar J       Date:  2008-06-26       Impact factor: 2.979

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.